@edikb
 Charlottesville, VA
Joined June 2010
  • Tweets119
  • Following219
  • Followers47
7Media
Here's a direct link to the paper published in JAMIA Open: doi.org/10.1093/jamiaopen/oo…. This #openaccess article highlights how @MPishvaian and @Perthera's network of experts have made #PrecisionOncology more scalable and accessible to patients across the country through technology

A virtual molecular tumor board to improve efficiency and scalability of delivering precision...

AbstractObjectives. Scalable informatics solutions that provide molecularly tailored treatment recommendations to clinicians are needed to streamline preci

academic.oup.com
UT MD Anderson
@UTMDAnderson18 Oct 2019
“A virtual molecular tumor board allows for deep discussions and insight into many aspects of a person’s unique cancer profile,” says our @MPishvaian: bit.ly/31sPzZE @ASCOPost #endcancer
3
2
.@YehlabUNC presenting @PanCAN Know Your Tumor data from @MPishvaian showing survival benefit of #pancreaticcancer patients receiving #precisionmedicine matched therapy. #AACRpan22
1
6
1
29
I'm expecting this to be a more exciting Jedi/padawan showdown than this week's obi-wan episode #pancsm #ASCO22 #medwitter @MPishvaian @marshalj23
Cure GI Cancers
@RueschCenter3 Jun 2022
Looking forward to a great discussion on the latest in #biomarker driven treatment in #GI, #colorectal #pancreatic, and #hepatobiliary cancers with @marshalj23, @mdmanishshah, and @MPishvaian. Sign up here- tinyurl.com/353jxdy6 to watch virtually. @CCO_Education #ASCO22
2
Great to see a shoutout to our @Perthera @PanCAN paper in @LancetOncology led by @MPishvaian at #asco22 during the Friday "Can We Begin to Predict Responders to Targeted Therapy in Gastrointestinal Cancer?" Session! pubmed.ncbi.nlm.nih.gov/3213…
Dr Joseph McCollom DO
@realbowtiedoc3 Jun 2022
Dr Thomas Seufferlein of @UniklinikUlm shows promising data that there could be hidden subpopulations that when matched with targeted therapy may impact treatment outcomes in #pancsm #GIonc #ASCO22
5
10
Dr Thomas Seufferlein of @UniklinikUlm shows promising data that there could be hidden subpopulations that when matched with targeted therapy may impact treatment outcomes in #pancsm #GIonc #ASCO22
2
1
3
📢In preparation for #ASCO22, I wanted to present my list for the #PancreaticCancer abstracts to👀for @ASCO Again,🙏note - I went through a LOT of abstracts, and I definitely may have missed some‼️ 👉And these are not in any particular order ✅But enjoy, RT, and reply😀
4
29
6
116
It was?? That's AWESOME‼️😃🎉 🙏so much @CDebyaniPhD for 👉this Huge CONGRATS for SUCH a TEAM🏅effort @DrHendifar @edikb @Perthera Brian Wolpin @VivekSubbiah Erik Collisson Isha Singh Tim Cannon @kennamshaw Chip Petricoin @KlempnerSam @EmilyLyons87 @WangGillam @EileenMOReilly
Debyani Chakravarty, PhD 🇺🇦@CDebyaniPhD13 Dec 2021
Congrats @EileenMOReilly @MPishvaian @DrHendifar & Edik Blais for their impt article re RAS family alterations in #PancreaticCancer & their real world outcomes in resp to MAPK pathway inhibitors. Most downloaded @JCOPO_ASCO article in 2021! bit.ly/3ES375x Into OncoKB!
8
23
"Because the alterations are so rare, 1 single institution wouldn’t be able to draw conclusions about the best treatment approaches" @EmilyLyons87 @PanCAN - wonderful example of collaboration for the benefit of #pancreaticcancer patients! 💜
PanCAN
@PanCAN25 Aug 2021
We're excited to announce a paper published today in @ASCO_Pubs #JCOPO that looks at the outcomes of #pancreaticcancer patients with alterations to the RAF gene and treatment targeted to that genetic alteration. Learn more at pcan.at/3x729b

New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

Pancreatic cancer patients whose treatment matches their biology can live longer. PanCAN and partners published a study providing clinical outcomes for patients with tumors with RAF alterations.

pancan.org
1
5
15
Ed NFkB retweeted
PanCAN
@PanCAN25 Aug 2021
Replying to @PanCAN @ASCO_pubs
Amazing collaboration w/ @DrHendifar @CSCancerCare @edikb @MPishvaian @Perthera @DanaFarber @VivekSubbiah @kennamshaw @MDAndersonNews @UCSFCancer @EileenMOReilly @sloan_kettering @GeorgeMasonU @WUSTLmed @hopkinskimmel @EmilyLyons87 @PanCAN
5
11
Ed NFkB retweeted
PanCAN
@PanCAN25 Aug 2021
We're excited to announce a paper published today in @ASCO_Pubs #JCOPO that looks at the outcomes of #pancreaticcancer patients with alterations to the RAF gene and treatment targeted to that genetic alteration. Learn more at pcan.at/3x729b

New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

Pancreatic cancer patients whose treatment matches their biology can live longer. PanCAN and partners published a study providing clinical outcomes for patients with tumors with RAF alterations.

pancan.org
1
9
1
18
🚨Hot off the press 👉Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes. Kudos to @PanCAN team @EmilyLyons87 @arosenzweig19 @DrHendifar @MPishvaian @kennamshaw et al for the collaboration & perseverance @ASCO_pubs bit.ly/3kvNg3E
2
24
43
#PrecisionMedicine 🚨 in #pancreaticcancer @PanCAN @lustgartenfdn @paNCfoundation Lead @MPishvaian and Andrew Hendifar through @accru__network @MayoCancerCare Binimetinib & Encorafenib in Pancreatic Cancer in tumors With a Somatic #BRAFV600E Mutation clinicaltrials.gov/ct2/show/…
8
21
Dear Colleagues at #ASCO20 A great pleasure to present OUR TOP #OncoAlert 🚨abstracts as picked by our expert colleague @MPishvaian Hope they help everyone navigate the meeting in terms of #GI #Cancers #CRCSM #colorectalcancer #Cholangiocarcinoma Best @weoncologists
6
1
14
Our #ASCO20 #RealWorldEvidence poster on #KRAS variants in pancreatic cancer is now online! Novel association between KRAS Q61 & shorter PFS on FOLFIRINOX being explored with @DrHendifar @MPishvaian #pancsm perthera.com/asco20/
9
1
16
Check out our @ASCO poster on #KRAS variants in pancreatic cancer using #RealWorldEvidence from the @Perthera platform for #PrecisionOncology; exploring KRAS Q61 as a novel biomarker for shorter PFS on FOLFIRINOX with @DrHendifar @MPishvaian et al perthera.com/asco20/
6
10
Our #CGP analysis @DrHendifar of #KRAS variants and their prognostic/predictive implications in #pancsm including poorly described #KRASQ61 #KRASWT tumors also w/actionable targets poster tomorrow 5/29/20 collab w/@Perthera @PanCAN @CSCancerCare meetinglibrary.asco.org/reco… – at Los Angeles, CA
7
10
Ed NFkB retweeted
PanCAN
@PanCAN3 Apr 2020
.@PanCAN’s chief science officer, @LynnMatrisian, sits down with @LetsWinpc to discuss the exciting study published in @TheLancet Oncology earlier this year on molecular profiling for #pancreaticcancer patients. letswinpc.org/promising-scie…
7
1
16
Thanks to @MPishvaian and @PanCAN and KYT program!
Alan Burguete-Torres M.D.@dralanburguete31 Mar 2020
I had to borrow your slide Professor @EileenMOReilly, to show it to my Med Onc residents in e-class and stress the importance of mutation analysis of PDAC.
1
6
1
27
Genetically targeted therapy significantly extended survival for patients with pancreatic cancer compared with standard chemo, according to study in @TheLancetOncol let by Michael Pishvaian MD @MPishvaian @hopkinskimmel bit.ly/38nZOlp #PrecisionMedicine
4
3
New research reveals #PancreaticCancer patients who receive precision medicine live an average of one year longer than those who do not. @MPishvaian @Perthera @PanCAN bit.ly/39wvir3
3
6
Congrats to @PanCAN on the great results in advanced #PancreaticCancer Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial thelancet.com/journals/lanon…
34
4
87
Load more